We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
127 hedge funds and large institutions have $69.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 50 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
488% more call options, than puts
Call options by funds: $382K | Put options by funds: $65K
2% less funds holding
Funds holding: 130 → 127 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
16% less capital invested
Capital invested by funds: $83.3M → $69.9M (-$13.4M)
40% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 50
Holders
127
Holders Change
-3
Holders Change %
-2.31%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
30
Reduced
50
Closed
13
Calls
$382K
Puts
$65K
Net Calls
+$317K
Net Calls Change
+$9K
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.57M |
| 2 |
Goldman Sachs
New York
|
-$816K |
| 3 |
Millennium Management
New York
|
-$594K |
| 4 |
E
Ergoteles
New York
|
-$447K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$403K |
